Abnormal gut-associated lymphoid tissue (GALT) in humans is associated with infectious and autoimmune diseases, which cause dysfunction of the gastrointestinal (GI) tract immune system. To aid in investigating GALT pathologies in vivo, we bioengineered a human-mouse chimeric model characterized by the development of human GALT structures originating in mouse cryptopatches. This observation expands our mechanistic understanding of the role of cryptopatches in human GALT genesis and emphasizes the evolutionary conservation of this developmental process. Immunoglobulin class switching to IgA occurs in these GALT structures, leading to numerous human IgAproducing plasma cells throughout the intestinal lamina propria. CD4 + T cell depletion within GALT structures results from HIV infection, as it does in humans. This human-mouse chimeric model represents the most comprehensive experimental platform currently available for the study and for the preclinical testing of therapeutics designed to repair disease-damaged GALT.
INTRODUCTION
The mammalian gastrointestinal (GI) tract contains a wellorganized immune system consisting of the gut-associated lymphoid tissues (GALTs) and the diffuse intestinal lamina propria. GALT includes Peyer's patches (PPs) and isolated lymphoid follicles (ILFs) where antigen-primed T and B cells are activated. These cells then migrate into the lamina propria where protective immune responses against invasive microorganisms and pathogenic toxins occur (McGhee et al., 2007; Pabst, 2012) . GALT and lamina propria are distinct tissues that together form the GI tract immune system that is critically important in the maintenance of health by providing a protective barrier between the host and a GI microbial ecosystem (Hooper and Macpherson, 2010; Pabst, 2012) . A key component of this activity is IgA production because this molecule inhibits bacterial penetration into intestinal tissue and aids in the maintenance of symbiotic relationships formed between beneficial commensal microbiota and the host (Hooper and Macpherson, 2010; McGhee et al., 2007; Pabst, 2012) . Because a functional GALT is an essential component of the GI tract immune system, immune dysfunctions associated with abnormalities of the GALT lead to major health concerns (Brenchley and Douek, 2008; Khor et al., 2011) . For example, HIV infection causes massive CD4 + T cell depletion in the GI tract immune system (Brenchley and Douek, 2008; Mehandru et al., 2004) . The resulting dysfunction has been linked to abnormal microbial translocation and immune activation, resulting in increased morbidity and mortality in HIV-infected individuals (Brenchley et al., 2006) . Inflammatory bowel diseases (IBDs) (i.e., ulcerative colitis and Crohn's disease) also have major physical manifestations that cause long-term patient distress (Khor et al., 2011) due primarily to overactive GALT (e.g., anomalous hyperplasia of ILFs that leads to excess production of the proinflammatory tumor necrosis factor [TNF]-a) (Yeung et al., 2000) . Successfully achieving our goal of generating an in vivo xenograft model characterized by the presence of human GALT would greatly benefit research focused on gaining a comprehensive understanding of the mechanisms that lead to these GALT pathologies. Furthermore, the availability of such a model would fill a critical need for an in vivo experimental platform for preclinical efficacy testing of therapeutic interventions to treat infectious and autoimmune diseaseinduced GALT pathologies.
In mice, the molecular and cellular mechanisms by which GALT develops have been extensively characterized. ILF formation is environmentally induced postnatally by commensal microbiota and requires cryptopatches containing lymphoid tissue inducer (LTi) cells-a distinct population of group 3 innate lymphoid cells (Eberl, 2005; Lorenz et al., 2003; Spits et al., 2013; van de Pavert and Mebius, 2010) . During ILF genesis, intestinal epithelial cells produce IL-7 that signals via the IL-7 receptor on LTi cells to induce the expression of lymphotoxin a 1 b 2 (LT-a 1 b 2 ) (Eberl, 2005; van de Pavert and Mebius, 2010) . LT-a 1 b 2 binds to the lymphotoxin b receptor (LTbR) on resident lymphoid tissue organizer (LTo) cells to upregulate the expression of chemokines (e.g., CXCL13, CCL19, and CCL21) and adhesion molecules (e.g., VCAM1 and ICAM1) for the recruitment and retention of lymphocytes into the cryptopatches (Eberl, 2005; van de Pavert and Mebius, 2010) . This cell-tocell signaling cascade reveals that IL-7R signaling is absolutely essential for GALT genesis such that normal GALT development fails to occur in mice with impaired IL-7R signaling, including IL-7Ra null mice and mice lacking the common g chain (IL-2Rg null mice) (Hamada et al., 2002; Ivanov et al., 2006) .
In contrast to our significant knowledge of GALT genesis in mice, this process is poorly understood in humans. Cryptopatches have been considered absent in humans (Moghaddami et al., 1998; Pabst et al., 2005) ; however, a recent histological study revealed the presence of cryptopatch-like structures in human gut (Lü gering et al., 2010) . This key observation led us to test whether mouse cryptopatches could serve as anlagen for human GALT genesis using a chimeric model. For these studies, we used bone marrow-liver-thymus (BLT) humanized mice Lan et al., 2006; Melkus et al., 2006) constructed in two closely related, lymphocytelacking, immunodeficient mouse strains that differ in their ability to develop cryptopatches (i.e., NOD/SCID (N/S] and NOD/SCID IL-2Rg null [NSG] ). Specifically, N/S mice have cryptopatches, whereas NSG mice lack these structures because of the absence of a functional IL-2Rg chain. We hypothesized that the cryptopatches of N/S mice could serve as anlagen for the development of human GALT in BLT humanized N/S (N/S-BLT) mice. Accordingly, we show that human GALT structures develop in the host cryptopatches of N/S-BLT mice. Moreover, HIV infection of N/S-BLT mice results in specific human CD4 + T cell depletion in the GALT structures. These observations highlight the potential of this model for the study of human GALT development in vivo and for performing preclinical evaluation of therapeutic interventions designed to treat important GALT-associated clinical conditions.
RESULTS
Cryptopatches Containing LTi Cells, the Anlagen for GALT Genesis, Are Present in N/S but Not NSG Mice To establish a baseline for GALT genesis in N/S and NSG mice, we examined the GI tract of nonhumanized mice. Immunocompetent BALB/c mice were used as a reference and positive control for the identification of cryptopatches and other relevant GALT structures in mice. We found that cryptopatches develop between the intestinal crypts in N/S, but not NSG, mice ( Figure 1A ). Immunofluorescence analysis (IFA) revealed that N/S and BALB/c mouse cryptopatches contain mouse IL-7Ra ( m IL-7Ra) + cells and m CD11c + dendritic cells ( Figure 1B) . In immunocompetent mice, infiltrating lymphoid cells typically expand cryptopatches into ILFs (Eberl, 2005; Eberl and Littman, 2004; van de Pavert and Mebius, 2010) . Interestingly, although N/S and NSG mice lack mouse T and B cells (Shultz et al., 2005) (Figures 1B-1D) , the cryptopatches in N/S mice become enlarged with a follicle-associated epithelium that is morphologically similar to BALB/c mouse GALT (e.g., ILFs and PPs) ( Figure 1A) . These enlarged structures in N/S mice contain m IL-7Ra + cells and m CD11c + dendritic cells, and they lack the lymphoid follicles composed of m CD3 + T and m B220 + B cells that are found in BALB/c mouse GALT ( Figure 1B ). We used polychromatic flow cytometry to analyze cells isolated from small intestines (SIs) of these mice. Within the mouse lineage marker ( m CD3, m B220, m CD11b, m Gr-1, and m TER-119) negative population, we identified m IL-7Ra + m c-kit + innate lymphoid cells in N/S and BALB/c, but not NSG, mice (Figures 1E and 1F) . Further examination of the m IL-7Ra + m c-kit + innate lymphoid cells revealed that a small fraction of this population also expressed m CD4, which defined these cells as LTi cells (Spits et al., 2013) ( Figure S1A ). However, the majority of the m IL-7Ra + m c-kit + population also expressed m NKp46 + , which defined these cells as a separate subset of group 3 innate lymphoid cells known as natural cytotoxicity-triggering receptor (NCR) + cells ( Figure S1A ) (Spits et al., 2013) . These cells were primarily located in the lamina propria of N/S mice and were not present in NSG mice ( Figure S1B ). Together, these results demonstrate that N/S mice have cryptopatches containing LTi cells that could serve as potential anlagen for the development of human GALT in their GI tract.
Reconstitution of N/S-BLT and NSG-BLT Mice with Human Hematopoietic Cells
For our study, we utilized 26 BLT mice exhibiting comparable systemic humanization (N/S-BLT, n = 13; NSG-BLT, n = 13). Specifically, the average percentage of h CD45 + cells in the peripheral blood of N/S-BLT mice was 52% (±20% SD), of which 71% (±21% SD) was h CD3 + T cells, and 15% (±19% SD) was h CD19 + B cells. Similarly, the average percentage of h CD45 + cells in the peripheral blood of NSG-BLT mice was 71% (±13% SD), of which 80% (±18% SD) was h CD3 + T cells, and 9% (±14% SD) was h CD19 + B cells. Systemic reconstitution with human hematopoietic cells in peripheral tissues (e.g., spleen, liver, lung) was comparable between N/S-BLT and the NSG-BLT mice (data not shown; Denton et al., 2012) . Therefore, these two types of BLT mice, one with and one without cryptopatches, were specifically chosen to test our hypothesis that cryptopatches can serve as suitable anlagen or foundation for human GALT development.
Development of Human GALT Structures in N/S-BLT Mice
When we examined the GI tract immune system in N/S-BLT and NSG-BLT mice, we noted that expanded immune aggregates were present in the SIs of 13 of 13 N/S-BLT mice, whereas none was present in the SIs of 13 NSG-BLT mice ( Figure 2A ) (p < 0.0001, Fisher's exact test). This highly reproducible observation was consistent with our hypothesis. Polychromatic flow cytometry analysis with cells isolated from the SIs of N/S-BLT humanized mice revealed that human group 3 innate lymphoid cells ( h CD3 neg h CD4 neg h CD45 + h IL-7Ra + h c-kit + ; Spits et al., 2013) are present, albeit in very small numbers ( Figure S1C ). IFA of the immune aggregates present in the SIs revealed that h CD45 + cells accumulated into cryptopatches together with m CD45 + cells ( Figure 2B ). As they expanded, these lymphoid aggregates harbored greater numbers of h CD45 + cells than m CD45 + cells ( Figure 2B ). Moreover, the human hematopoietic lineages present in expanded lymphoid aggregates included h CD3 + T cells, h CD19 + B cells, h CD11c + dendritic cells, and h CD68 + macrophages ( Figure 3A ), defining these as human GALT structures (Jung et al., 2010) . The specificity of all the antibodies to human antigens used in our analyses was carefully confirmed by parallel staining of tissues obtained from nonhumanized N/S and NSG mouse intestines (data not shown). In summary, the presence or absence of cryptopatches in the two different strains used to generate BLT mice corresponded directly to the presence or the lack of human GALT structures.
Comprehensive Characterization of the GI Tract Human Immune Reconstitution in BLT Mice
The GI tract immune system consists of multiple compartments: GALT, diffuse lamina propria, and an epithelial cell monolayer harboring intraepithelial lymphocytes (McGhee et al., 2007; Pabst, 2012) . GALT is where mature naive B cells differentiate into class-switched IgA + cells that localize to the intestinal lamina propria (McGhee et al., 2007; Pabst, 2012) . Intraepithelial lymphocytes in N/S-BLT mice include human CD8 + T cells, CD4 + T cells, natural killer cells, and myeloid dendritic cells, but not gd T cells . The difference observed in the ability of human GALT to develop in N/S-BLT versus NSG-BLT mice led us to hypothesize that this difference would influence the human immune cell lineages present in the mouse intestinal lamina propria. Therefore, we performed flow cytometry analyses on cells isolated from SIs. We found equivalent numbers of h CD3 + T cells in both types of BLT mice ( Figures 3B and 3C) . In contrast, the number of h CD19 + B cells was significantly higher in N/S-BLT versus NSG-BLT mice ( Figures 3B and 3C) .
We next used IFA to characterize the human immune cells in the intestinal lamina propria of BLT mice. In comparison to the relative abundance of human B cells present in the GALT structures of N/S-BLT mice, h CD19 + B cells were infrequent in the lamina propria of both N/S-BLT and NSG-BLT mice ( Figure 3D ). In contrast, h CD3 + T cells, h CD11c + dendritic cells, and h CD68 + macrophages were identified here in both types of BLT mice ( Figure 3D ). The restricted distribution of human B cells in the human GALT structures of N/S-BLT mice was confirmed using a second pan B cell marker, h CD20 ( Figure S2A) .
The pan B cell surface markers (CD19 and CD20) are appropriate to study the distribution of human B cells at most stages of differentiation; however, the reduction or disappearance of these markers on fully differentiated B cells precludes their utilization to determine the presence of plasma cells (Benckert et al., 2011; Farstad et al., 2000) . Therefore, other B cell differentiation markers were used to investigate the intestinal plasma cells in N/S-BLT mice. In the GALT structures, we found cells expressing human activation-induced cytidine deaminase (AID) ( Figure S2A ). This observation is consistent with the presence of classswitched h IgA + and h IgG + cells ( Figure S2A ). In addition, h IgM + cells were also found in these structures ( Figure S2A ). The antih IgM antibody (Taylor and Burns, 1974) used for this IFA is strongly reactive with plasma cells producing h IgM, but not with mature naive B cells bearing surface h IgM, defining the h IgM + cells found in the GALT structures as unswitched h IgMproducing plasma cells.
To investigate the maturation of B cells to h IgA-producing plasma cells, we performed additional IFAs. We found that all h IgA + cells were consistently negative for h CD20 expression, whereas some h IgA + cells expressed HLA-DR, another mature naive B cell marker (Farstad et al., 2000) ( Figure S2B ). h CD27, h CD38, or h CD138 was also expressed on some h IgA + cells, confirming their status as fully differentiated plasma cells ( Figure S2B ) (Farstad et al., 2000) . These results indicate that the human GALT structures contain heterogeneous h IgA + cell populations at multiple differentiation stages. Quantitative IFA revealed that the SI lamina propria of N/S-BLT mice harbors more h CD45 + h IgA + cells versus h CD45 + h IgM + cells or h CD45 + h IgG + cells ( Figures 4A and 4B) . In contrast, very few h CD45 + cells expressing h IgA, h IgM, or h IgG were found in NSG-BLT mice (Figures 4A and 4B) . These results confirmed our hypothesis that the presence of most human plasma cells in the intestinal lamina propria of BLT mice is dependent on the presence of human GALT structures. Furthermore, the fact that N/S-BLT mice have cryptopatches (Figure 2) , together with the fact that intraepithelial T cell numbers are significantly higher in N/S-BLT mice relative to NSG-BLT mice , suggests that intraepithelial lymphocyte reconstitution is partially cryptopatch/GALT dependent. Despite the absence of GALT structures in NSG-BLT mice, their lamina propria contained a small number of h CD45 + h Ig + cells ( Figures 4A and 4B ). We hypothesized that the presence of human cells in the gut-draining mesenteric lymph nodes (MLNs) could explain this observation. Our hypothesis was based on the following key facts: (1) both GALTs and MLNs are sites where human IgA + cells, in addition to T cells, are programmed to migrate into the intestinal lamina propria (Mora and von Andrian, 2009); (2) a functional IL-7R is dispensable for the development of MLN anlagen (Cao et al., 1995) ; and (3) cryptopatch formation is completely dependent on IL-7R signaling (Kanamori et al., 1996) . We found that the MLNs in both Figure S3 ). We also found class-switched h IgA + and h IgG + cells and unswitched h IgM + cells in the MLNs of both types of BLT mice ( Figure S3 ). These results are consistent with our hypothesis that h Ig + cells in the lamina propria of NSG-BLT mice could originate from the MLNs.
IgA1-and IgA2-Secreting Plasma Cells in the Lamina Propria of N/S-BLT Mice
A hallmark of the human GI tract immune system is the secretion of IgA in the intestinal lamina propria (McGhee et al., 2007; Pabst, 2012) . We used ELISPOT analyses to quantitate the antibodysecreting plasma cells in the SIs of N/S-BLT and NSG-BLT mice. N/S-BLT mice harbored more h IgA-secreting plasma cells than h IgG-secreting plasma cells ( Figures 5A and 5B) . In contrast, NSG-BLT mice had few plasma cells secreting h Ig in general and fewer plasma cells secreting h IgA and h IgG versus N/S-BLT mice ( Figures 5A and 5B ). Consistent with human data (Farstad et al., 2000) , we found that h IgA + cells in the SI lamina propria of N/S-BLT mice exhibited a surface expression profile indicative of fully differentiated human plasma cells (i.e., h CD20 neg HLA-DR neg h CD27 + h CD38 + h CD138 + ) ( Figure 5C ). In humans, there are two IgA subclasses: h IgA1 and h IgA2 (Mestecky et al., 1999) . Like in humans, both are present in the GALT structures and the intestinal lamina propria of N/S-BLT mice ( Figures 5D and S4 ). Together, these results emphasize similarities between the N/S-BLT and the human GI tract immune systems, indicating that N/S-BLT mice are suitable for the study of GALT pathologies.
GALT Destruction in N/S-BLT Mice after HIV Infection
HIV infection results in a catastrophic loss of CD4 + T cells in the GI tract that is not fully reflected in the periphery (Brenchley and Douek, 2008) . Analysis of the human T cells in the GALT structures of N/S-BLT mice showed that, like in healthy humans (Mehandru et al., 2004) , there is a preponderance of CD4 + T cells. Specifically, the CD4/CD8 T cell ratio in the GALT structures of N/S-BLT mice was 1.84 (±0.19 SD), well within the range (1.6-3.1) reported for healthy human GALT (Mehandru et al., 2004) . After rectal exposure, HIVgag p24 -expressing cells are present in the GALT structures of N/S-BLT mice ( Figure S5A ). Our results show a 7.6-fold reduction in the number of h CD4 + T cells in the GALT structures of these mice due to HIV infection ( Figure S5B) , which is consistent with our previous flow cytometry-based observation that HIV infection decreased h CD4 + T cells in the intestinal lamina propria and intraepithelial compartments Sun et al., 2007) . In contrast, there was no observed difference in h CD8 + T cell levels in HIV neg versus HIV + animals ( Figure S5C ). Consistent with HIV patient data (Mehandru et al., 2007) , h perforin + cells were significantly increased in the GALT structures of HIV + N/S-BLT mice (Figure S5D) . These findings highlight the accurate manner in which N/S-BLT mice recapitulate CD4 + T cell depletion in the GALT structures.
Overall, these results support the following model for the development of human GALT structures in N/S-BLT mice. First, endogenous cryptopatches are populated with mouse LTi cells that provide an appropriate local microenvironment for the recruitment of human hematopoietic cells. Then recruited human CD4 + T cells, CD8 + T cells, B cells, dendritic cells, and macrophages develop human GALT structures. Human B cells in these structures express AID and differentiate into IgA-producing plasma cells that migrate to the intestinal lamina propria. Once established, these GALT structures are susceptible to HIVinduced depletion of h CD4 + T cells, further demonstrating how human GALT structures in N/S-BLT mice recapitulate key phenotypes of human GALT during health and disease.
DISCUSSION
The human GI tract immune system is critically important in the defense against intestinal pathogens and the maintenance of immune tolerance to commensal microorganisms (Hooper and Macpherson, 2010; McGhee et al., 2007; Pabst, 2012) . These activities represent a delicate balance that is susceptible to disruption in patients with GALT-damaging infectious or autoimmune diseases (Brenchley and Douek, 2008; Khor et al., 2011) . In vivo studies of GALT genesis, biology, and pathology have significant difficulties that are intrinsic to human studies. Reproducing human GALT biology using ex vivo organ cultures has proven to be challenging (Hicks et al., 1996) . If available, an in vivo xenograft model that recapitulates human GALT development and pathologies could offer the following advantages to GALT research: (1) much longer experimental window (>6 months) relative to ex vivo approaches (48 hr) (Hicks et al., 1996) ; (2) much larger tissue sample (entire intestine with GALT) relative to ex vivo samples (2-3 mm 2 biopsy specimens) (Hicks et al., 1996) ; (3) mechanisms contributing to human GALT genesis can be studied; (4) permits interorgan cell migration patterns to and from GALT; (5) physiological methods to induce GALT pathogenesis (e.g., mucosal HIV transmission; Sun et al., 2007) ; (6) multiple organs can be harvested simultaneously facilitating comparative analyses with GALT; and (7) human GALT cells exposed to human pathogens in vivo can be targeted by human therapeutics. To gain these experimental advantages in GALT research, we bioengineered an appropriate xenotransplantation model.
In mice, cryptopatches serve as anlagen for the postnatal formation of ILFs (Eberl, 2005; Eberl and Littman, 2004 ; van de (legend continued on next page) Pavert and Mebius, 2010). This information, coupled with the recent description of cryptopatch-like structures in human intestines (Lü gering et al., 2010) , led us to hypothesize that mouse cryptopatches may serve as anlagen for human GALT genesis.
To test this hypothesis, we needed strains of immunodeficient mice with or without cryptopatches in their GI tract and a humanization strategy that would result in the in situ development and systemic dissemination, including throughout the GI tract, of human hematopoietic cells. We identified two closely related immunodeficient mouse strains (N/S and NSG) that differ genetically only at the IL-2Rg chain locus, leading to a differential phenotype in their ability to develop cryptopatches. Of the multiple strategies described for the humanization of immunodeficient mouse strains (Denton and García, 2011; Shultz et al., 2007 Shultz et al., , 2012 , BLT humanization was chosen because it results in development of human T cells in N/S mice and reproducible human reconstitution of mouse intestines . This information combined with the lack of detailed information regarding human GALT structure development in BLT mice led us to utilize the BLT humanization strategy coupled with the utilization of the N/S and NSG mouse strains to test our hypothesis that mouse cryptopatches may also serve as anlagen for human GALT genesis. Confirming our hypothesis, a major finding of these studies is the demonstration that endogenous cryptopatches in the SIs of N/S mice serve as anlagen for the development of human GALT structures following BLT humanization (Figure 2) . These GALT structures contain human T cells, B cells, dendritic cells, and macrophages (Figure 3) , indicating that homing molecules produced by mouse LTo cells in cryptopatches cross-react sufficiently with their corresponding receptors on human hematopoietic cells to induce GALT formation. The critical role for cryptopatches in human GALT development is highlighted by the fact that cryptopatch-lacking NSG-BLT mice do not develop human GALT structures (Figure 2) . The abundance of human T cells, B cells, dendritic cells, and macrophages in all peripheral tissues of NSG-BLT mice does not rescue the GALT-deficient phenotype in these animals. These observations represent a fundamental breakthrough in our mechanistic understanding of the role of cryptopatches in human GALT genesis.
A second major finding is that human B cells in the GALT structures of N/S-BLT mice recapitulate essential roles of B cells present in human GALT (He et al., 2007; Spencer et al., 2012) . As in human intestines (He et al., 2007; Mestecky et al., 1999; Spencer et al., 2012) , in N/S-BLT mice, h IgA1 + and h IgA2 + cells are present in both the GALT structures and the lamina propria (Figure 5) . A difference we noted was a slightly inverted ratio of h IgA1 + and h IgA2 + cells relative to human data ( Figure S4) (He et al., 2007; Mestecky et al., 1999; Spencer et al., 2012) . This could be due to either the chimeric intestinal environment and/or the differential commensal microbiota between humans and mice (Denton and García, 2011; Shultz et al., 2007 Shultz et al., , 2012 Turn-baugh et al., 2009) . Overall, our findings highlight the many similarities between GALT structures of N/S-BLT mice and human GALT.
In conclusion, here, we modeled human GALT development and pathogenesis in vivo using a human-mouse chimeric model. Key mechanistic discoveries include the demonstration that mouse cryptopatches can initiate human GALT genesis, demonstration that human intestinal IgA production is initiated in the GALT structures, and the depletion of human CD4 + T cells in the GALT structures as a result of HIV infection. Our findings have significant potential to stimulate further research on GALT damage or malfunction as observed in HIV disease and IBDs. The histology-based analyses of the GALT structures present in HIV-infected N/S-BLT mice presented here exemplify possible analyses in this model, which is the most comprehensive experimental platform currently available for the study and the preclinical efficacy testing of therapeutics designed to repair disease-damaged GALT.
EXPERIMENTAL PROCEDURES
Human-Mouse Chimeric Model N/S (NOD.CB17-Prkdc scid /J), NSG (NOD.Cg-Prkdc scid Il2rg tm1Wjl /Szj), and BALB/c mice were obtained from The Jackson Laboratory. All mice were maintained either at the Division of Laboratory Animal Medicine at the University of North Carolina at Chapel Hill or the Animal Resources Center at the University of Texas Southwestern Medical Center at Dallas in accordance with protocols approved by each institution's Institutional Animal Care and Use Committee. N/S-BLT (n = 13) or NSG-BLT (n = 13) mice were prepared essentially as previously described Melkus et al., 2006) . Tissue for implantation was obtained from Advanced Bioscience Resources. Human reconstitution in the peripheral blood of BLT mice was monitored by polychromatic flow cytometry with the directly conjugated antibodies described in Table S1 .
Histological and Cellular Analyses
SIs, large intestines, MLNs, spleens, livers, and lungs were harvested, fixed with 4% paraformaldehyde (Sigma-Aldrich), and embedded in either paraffin (Leica) or OCT compound (Sakura). Tissue sections (5 mm) were analyzed as detailed in the Extended Experimental Procedures. Antibodies utilized for histological analyses are described in Tables S2 and S3 . SIs of BLT mice and control BALB/c mice were processed to isolate lamina propria mononuclear cells essentially as previously described by Sun et al. (2007) . Cells were utilized for ELISPOT as detailed in the Extended Experimental Procedure. All statistical analyses (a level, 0.05) were performed in Prism version 5 (GraphPad).
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(D) h IgA1-and h IgA2-producing plasma cells are found in both the human GALT structures and the lamina propria of N/S-BLT mice. Images include polyclonal anti-hIgA with binding specificities for both h IgA1 and h IgA2 (green, left), monoclonal antibodies specific for either h IgA1 or h IgA2 (red, center), and the merged plus DAPI (right). Scale bars, 50 mm. See also Figure S4 . 
